Safety Data for Hep B Vax for Newborns Exposed

Data show public health experts do not protect the most vulnerable - our children. One group seeks to hold the FDA legally responsible for the scarcity of safety data for newborn shots.

STORY AT-A-GLANCE

• The safety data on Recombivax HB, the hepatitis B vaccine for newborns, are sadly lacking, as the FDA approved the shot based on clinical trials performed on only 147 infants and children and followed for only five days

• There are four hepatitis B vaccines, two of which are approved for infants; the second approved for infants is Engerix-…